Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Wang23x , 10.1101/2023.03.22.533805 #858

Closed
KaimingTao opened this issue Apr 4, 2023 · 2 comments
Closed

Wang23x , 10.1101/2023.03.22.533805 #858

KaimingTao opened this issue Apr 4, 2023 · 2 comments
Assignees
Labels
adv mAb MAb in advanced clinical stage MAb susceptibility data In vitro neutralization data of MAb Plasma susceptibility data In vitro neutralization data of CP and VP preprint This study is a preprint

Comments

@KaimingTao
Copy link
Member

No description provided.

@KaimingTao KaimingTao added Plasma susceptibility data In vitro neutralization data of CP and VP MAb susceptibility data In vitro neutralization data of MAb preprint This study is a preprint adv mAb MAb in advanced clinical stage labels Apr 4, 2023
@shegocaga shegocaga self-assigned this Apr 5, 2023
@shegocaga
Copy link
Collaborator

image

@KaimingTao When adding new isolates, do we have a rule about adding a variant with its mutations or a new variant altogether or both?
For example, in this case, we have DS.1 which is equivalent to BA.2.75 Spike:R346T+F486S+F490S+K356T+R403K, but I'm not sure if I should be adding one, the other, or both.

@KaimingTao
Copy link
Member Author

@zachandfox You can use DS.1, but I recommend to use BA.2.75 Spike:R346T+F486S+F490S+K356T+R403K because DS.1 is not a well-known name. We can change the name when it's well-known.

KaimingTao pushed a commit that referenced this issue Apr 12, 2023
* add wang23c

* update date_added

* add wang23c

* update date_added

* correct variant_consensus

* correct potency

* Autogenerated data updated by HIVDB Bot

* update subject counts

---------

Co-authored-by: HIVDB Bot <[email protected]>
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
adv mAb MAb in advanced clinical stage MAb susceptibility data In vitro neutralization data of MAb Plasma susceptibility data In vitro neutralization data of CP and VP preprint This study is a preprint
Projects
None yet
Development

No branches or pull requests

2 participants